INCY

Incyte Corporation

Industrials
128.83 +3.82 +3.06% Market Open
2026-09-02 • USD

Key Metrics

Market Cap 25.74B
EV 22.28B
Shares Out 199.78M
Revenue (ttm) 5.36B
Net Income 1.43B
Beta —
P/E —
Forward P/E —
EPS (ttm) $7.08
P/S 4.79
P/B 4.57
P/FCF 16.93
P/C 16.93
EV/Sales 4.16
EV/EBITDA 13.06
ROA 19.51%
ROE 29.24%
ROIC 23.1%
Gross Margin —
Oper. Margin 30.05%
Profit Margin 26.71%
Debt/Eq 0.00
LT Debt/Cap —
Quick Ratio 3.03
Current Ratio 3.68
Book/sh 28.21
Cash/sh 17.36
Div Yield —
Div TTM —
Payout Ratio —
SMA20 3.54%
SMA50 7.33%
SMA200 23.3%
Volume 2,324,205
Avg Volume 1.73M
Rel Volume 1.34
Perf Week 0.85%
Perf Month 8.78%
Perf Quarter 31.49%
Perf Half Y 31.37%
Perf YTD 30.43%
Perf Year 48.15%
Perf 3Y 99.15%
Perf 5Y 69.31%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. The Company's global headquarters is in…

Name
Incyte Corporation
Industry
Industrials
CEO
William J. Meury · Chief Executive Officer
Employees
3,200 as of 2025-12-31
IPO Date
2019-01-02
Phone
(302) 498-6700
Address
1801 Augustine Cut-Off, Wilmington, DE 19803
Website
https://www.incyte.com

Key Executives

Name Title FY Pay
Jean-Jacques Bienaimé Independent Director —
Julian C. Baker Chair of the Board —
Richard Hoffman Secretary —
Hervé Hoppenot President and Former Chief Executive Officer —
William J. Meury Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.